Global Big Pharma, Big Dividends

Hypera

Market Cap: R$14.5b

Operates as a pharmaceutical company in Brazil.

Chugai Pharmaceutical

Market Cap: JP¥11.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.7t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Bora Pharmaceuticals

Market Cap: NT$85.9b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Sino Biopharmaceutical

Market Cap: HK$149.3b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Eris Lifesciences

Market Cap: ₹221.3b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥75.8b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shenzhen Salubris Pharmaceuticals

Market Cap: CN¥67.3b

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Alembic Pharmaceuticals

Market Cap: ₹177.8b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

Beijing Aosaikang Pharmaceutical

Market Cap: CN¥19.2b

Beijing Aosaikang Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical

Market Cap: CN¥26.5b

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Hubei Jumpcan Pharmaceutical

Market Cap: CN¥22.4b

Engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China.

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥16.1b

Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.

Eli Lilly

Market Cap: US$741.0b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥16.7b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

Glenmark Pharmaceuticals

Market Cap: ₹552.9b

Develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥49.6b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥16.1b

Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.

Chengdu Kanghong Pharmaceutical Group

Market Cap: CN¥34.1b

Research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China.

Dermapharm Holding

Market Cap: €1.7b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.1b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Grand Pharmaceutical Group

Market Cap: HK$29.6b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

China Medical System Holdings

Market Cap: HK$34.0b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Lotus Pharmaceutical

Market Cap: NT$69.4b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$30.3b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Haw Par

Market Cap: S$3.2b

Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.

Gland Pharma

Market Cap: ₹326.5b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.